×

Intellectual Property Patents

  • WASHINGTON, March 27- The U.S. Supreme Court on Monday struggled over whether to upend nearly 30 years of law governing patent lawsuits that critics say allows often-baseless litigants to sue in friendly courts, giving them the upper hand over high-technology companies such as Apple Inc and Alphabet Inc's Google. The justices heard an hour of arguments in an...

  • WASHINGTON, March 27- The U.S. Supreme Court on Monday struggled over whether to upend nearly 30 years of law governing patent lawsuits that critics say allows often-baseless litigants to sue in friendly courts, giving them the upper hand over high-technology companies such as Apple Inc and Alphabet Inc's Google. The justices heard an hour of arguments in an...

  • LONDON, March 27- International groups representing doctors and patients have launched a fresh challenge to the patent on Gilead Sciences' hepatitis C drug sofosbuvir at the European Patent Office in order to increase access to the treatment. If the latest patent challenge is successful, it could make cheaper generic versions of sofosbuvir available in...

  • March 21- A U.S. Supreme Court ruling on Tuesday in a lawsuit over adult diapers will make it more difficult for companies accused of patent infringement to shoot down lawsuits because the plaintiffs waited too long to bring them. In a 7-1 decision, the justices said SCA Hygiene Products AB, based in Stockholm, did not unreasonably delay in filing a lawsuit...

  • Biogen wins patent decision

    CNBC's Meg Tirrell reports on the victory for Biogen in its patent case over its Multiple Sclerosis drug.

  • WASHINGTON— The Supreme Court says a company that makes adult diapers did not wait too long to sue a rival for copying its patented design. The justices ruled 7-1 Tuesday that Sweden- based SCA Hygiene Products AB could take legal action against New York- based First Quality Baby Products LLC for violating patents on its adult incontinence products.

  • Last month, the Broad Institute, a biological and genomic research center affiliated with MIT and Harvard, won a landmark ruling to keep valuable patents on CRISPR. Cambridge, Massachusetts- based Editas Medicine licenses CRISPR-related intellectual property from the Broad Institute. Editas had cash and cash equivalents of $185.3 million as of Dec. 31.

  • Pilot models of the Uber self-driving car is displayed at the Uber Advanced Technologies Center on September 13, 2016 in Pittsburgh, Pennsylvania.

    Alphabet's self-driving car unit Waymo added a new patent claim to its intellectual property lawsuit against Uber Technologies.

  • March 13- Data that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting this week as the future of the only rival drug rests with the courts in an ongoing patent dispute. Highly anticipated results from a 27,500- patient trial of Amgen Inc's Repatha will be presented on...

  • March 10- Alphabet Inc's self-driving car unit Waymo on Friday added a new patent claim to its intellectual property lawsuit against Uber Technologies Inc and requested a preliminary injunction to stop the ride-sharing service from using what it says is proprietary information, a court filing showed. The two Silicon Valley companies are fighting over...

  • March 10- Alphabet Inc's self-driving car unit Waymo on Friday added a new patent claim to its intellectual property lawsuit against Uber Technologies Inc and requested a preliminary injunction to stop the ride-sharing service from using what it says is proprietary information, a court filing showed. The two Silicon Valley companies are fighting over...

  • March 1- A federal appeals court has thrown out a jury verdict that had originally required Apple Inc to pay $533 million to Smartflash LLC, a technology developer and licenser that claimed Apple's iTunes software infringed its data storage patents. The trial judge vacated the large damages award a few months after a Texas federal jury imposed it in February...

  • A customer uses a credit card scanner at a Target store in Miami.

    The CNBC IQ 100 Index is whipping the S&P 500, and it just added a surprising stock: Target. The retailer is more innovative than Google.

  • Feb 21- The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices. Boston Scientific had asked the justices to hear its appeal in the dispute over its licenses...

  • Feb 15- The Broad Institute, a biological and genomic research center affiliated with MIT and Harvard, will keep valuable patents on a revolutionary gene-editing technology known as CRISPR, a U.S. patent agency ruled on Wednesday. Patent and Trademark Office's Patent Trial and Appeal Board in Alexandria, Virginia, rejected a claim by a rival team, associated...

  • Feb 15- The Broad Institute, a biological and genomic research center affiliated with MIT and Harvard, will keep valuable patents on a revolutionary gene-editing technology known as CRISPR, a U.S. patent agency ruled on Wednesday. Patent and Trademark Office's Patent Trial and Appeal Board in Alexandria, Virginia, rejected a claim by a rival team, associated...

  • Feb 15- The Broad Institute, a biological and genomic research center affiliated with MIT and Harvard, will keep valuable patents on a revolutionary gene-editing technology known as CRISPR, a U.S. patent agency ruled on Wednesday. Patent and Trademark Office's Patent Trial and Appeal Board in Alexandria, Virginia, rejected a claim by a rival team, associated...

  • Patent and Trademark Office's Patent Trial and Appeal Board in Alexandria, Virginia on Wednesday dismissed a claim by a rival team, associated with the University of California at Berkeley and the University of Vienna in Austria, to have invented the technology first.

  • Feb 8- A U.S. appeals court on Wednesday has stayed an order that would have blocked Regeneron Pharmaceuticals Inc and Sanofi SA from selling their cholesterol drug, Praluent, later this month while they appeal. A federal judge had earlier blocked sales of the drug after rival Amgen Inc won a trial in which it accused them of infringing its patents.

  • Jan 31- A bitter defeat in a U.S. patents case sent shares in Teva Pharmaceutical Industries plummeting on Tuesday, the latest in a series of setbacks that has investors calling for major changes at the world's largest generic drugmaker. A U.S. District Court on Monday rejected four out of five of Israel- based Teva's claims of patent infringement on its...